[Current aspects of arterial anti-thrombosis prophylaxis].
New prophylactic strategies for arterial thrombosis are built up following new discoveries about the thrombo-resistance of the vascular endothelium. To cope with the complexity of the interactions between platelets, erythrocytes and endothelium, it is logical to propose a multivalent prophylaxis, potent enough to control the multiple thombogenic factors. In this prospect, the combination acetyl-salicylic acid with dipyridamole presents an obvious complementarity, until confirmation of the clinical activity of other combinations.
Sternon
J
J
Service de Médecine Interne, Hôpital Erasme, U.L.B.
D000328:Adult; D000368:Aged; D001241:Aspirin / Q000009:adverse effects / Q000627:therapeutic use*; D000075202:Contraindications; D004176:Dipyridamole / Q000627:therapeutic use; D006801:Humans; D008875:Middle Aged; D009203:Myocardial Infarction / Q000517:prevention & control; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D013927:Thrombosis / Q000517:prevention & control*
D010975:Platelet Aggregation Inhibitors; D004176:Dipyridamole; D001241:Aspirin
Un nouveau regard sur la prophylaxie anti-thrombotique artérielle.